These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31527759)

  • 1. Nuclease dead Cas9 is a programmable roadblock for DNA replication.
    Whinn KS; Kaur G; Lewis JS; Schauer GD; Mueller SH; Jergic S; Maynard H; Gan ZY; Naganbabu M; Bruchez MP; O'Donnell ME; Dixon NE; van Oijen AM; Ghodke H
    Sci Rep; 2019 Sep; 9(1):13292. PubMed ID: 31527759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas-directed programmable assembly of multi-enzyme complexes.
    Lim S; Kim J; Kim Y; Xu D; Clark DS
    Chem Commun (Camb); 2020 May; 56(36):4950-4953. PubMed ID: 32239050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Gene Silencing in Leptospira biflexa by RNA-Guided Catalytically Inactive Cas9 (dCas9).
    Fernandes LGV; Nascimento ALTO
    Methods Mol Biol; 2020; 2134():109-122. PubMed ID: 32632863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9.
    Cui L; Vigouroux A; Rousset F; Varet H; Khanna V; Bikard D
    Nat Commun; 2018 May; 9(1):1912. PubMed ID: 29765036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Control of a CRISPR-Cas9 Acetyltransferase.
    Shrimp JH; Grose C; Widmeyer SRT; Thorpe AL; Jadhav A; Meier JL
    ACS Chem Biol; 2018 Feb; 13(2):455-460. PubMed ID: 29309117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
    Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
    Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 Type II-C system.
    Fedorova I; Arseniev A; Selkova P; Pobegalov G; Goryanin I; Vasileva A; Musharova O; Abramova M; Kazalov M; Zyubko T; Artamonova T; Artamonova D; Shmakov S; Khodorkovskii M; Severinov K
    Nucleic Acids Res; 2020 Feb; 48(4):2026-2034. PubMed ID: 31943070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
    Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
    Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulating the position of DNA expression cassettes using location tags fused to dCas9 (Cas9-Lag) to improve metabolic pathway efficiency.
    Xie Q; Li S; Zhao D; Ye L; Li Q; Zhang X; Zhu L; Bi C
    Microb Cell Fact; 2020 Dec; 19(1):229. PubMed ID: 33317552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels.
    Depardieu F; Bikard D
    Methods; 2020 Feb; 172():61-75. PubMed ID: 31377338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
    Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
    ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira.
    Fernandes LGV; Guaman LP; Vasconcellos SA; Heinemann MB; Picardeau M; Nascimento ALTO
    Sci Rep; 2019 Feb; 9(1):1839. PubMed ID: 30755626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA stretching induces Cas9 off-target activity.
    Newton MD; Taylor BJ; Driessen RPC; Roos L; Cvetesic N; Allyjaun S; Lenhard B; Cuomo ME; Rueda DS
    Nat Struct Mol Biol; 2019 Mar; 26(3):185-192. PubMed ID: 30804513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Type-Specific CRISPR Activation with MicroRNA-Responsive AcrllA4 Switch.
    Hirosawa M; Fujita Y; Saito H
    ACS Synth Biol; 2019 Jul; 8(7):1575-1582. PubMed ID: 31268303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional insights into the
    Zuo Z; Zolekar A; Babu K; Lin VJ; Hayatshahi HS; Rajan R; Wang YC; Liu J
    Elife; 2019 Jul; 8():. PubMed ID: 31361218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.